Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
13476
PUT
Arq
ARQ
$88.2M
| $12.1K | ﹤0.01% |
1,600
-7,900
| -83% | -$52K |
2023 Q4
4 quarters
|
|
13477
PUT
Invesco FTSE RAFI US 1000 ETF
PRF
$9.91B
| $12.1K | ﹤0.01% |
+300
| New | +$12.4K |
2024 Q4
0 quarters
|
|
13478
PUT
Telefônica Brasil
VIV
$20.2B
| $12.1K | ﹤0.01% |
1,600
+1,000
| +167% | +$8.9K |
2022 Q4
8 quarters
|
|
13479
CALL
Amtech Systems
ASYS
$312M
| $12K | ﹤0.01% |
2,200
+600
| +38% | +$3.4K |
2022 Q4
8 quarters
|
|
13480
PUT
ProShares Trust UltraShort Lehman 7-10 Year Treasury
PST
$11.5M
| $12K | ﹤0.01% |
500
-700
| -58% | -$16.4K |
2022 Q4
8 quarters
|
|
13481
PUT
Global X Cloud Computing ETF
CLOU
$385M
| $12K | ﹤0.01% |
500
-31,700
| -98% | -$724K |
2020 Q3
17 quarters
|
|
13482
PUT
T-Rex 2X Inverse NVIDIA Daily Target ETF
NVDQ
$15.5M
| $12K | ﹤0.01% |
180
+145
| +414% | +$10.1K |
2024 Q2
2 quarters
|
|
13483
PUT
State Street SPDR Portfolio Europe ETF
SPEU
$693M
| $12K | ﹤0.01% |
+300
| New | +$12.5K |
2024 Q4
0 quarters
|
|
13484
PUT
Fidelity MSCI Energy Index ETF
FENY
$2.12B
| $11.9K | ﹤0.01% |
500
-600
| -55% | -$15K |
2022 Q4
8 quarters
|
|
13485
CALL
Sol-Gel Technologies
SLGL
$258M
| $11.9K | ﹤0.01% |
1,280
+1,130
| +753% | +$7.06K |
2023 Q2
6 quarters
|
|
13486
PUT
YieldMax GOOGL Option Income Strategy ETF
GOOY
$228M
| $11.9K | ﹤0.01% |
+800
| New | +$12.1K |
2024 Q4
0 quarters
|
|
|
SLAI
13487
PUT
DELISTED
SOLAI Ltd ADS
SLAI
| $11.8K | ﹤0.01% |
671
+557
| +489% | +$11K |
2023 Q1
7 quarters
|
|
13488
PUT
eGain
EGAN
$156M
| $11.8K | ﹤0.01% |
+1,900
| New | +$10.1K |
2024 Q4
0 quarters
|
|
13489
CALL
Karyopharm Therapeutics
KPTI
$15.2M
| $11.8K | ﹤0.01% |
1,167
-3,100
| -73% | -$37.5K |
2018 Q3
25 quarters
|
|
13490
Dolphin Entertainment
DLPN
$14.3M
| $11.8K | ﹤0.01% |
11,049
-1,482
| -12% | -$1.78K |
2024 Q2
2 quarters
|
|
13491
CALL
Companhia Siderúrgica Nacional
SID
$1.64B
| $11.8K | ﹤0.01% |
8,200
+3,100
| +61% | +$6.07K |
2021 Q1
15 quarters
|
|
13492
CALL
Hamilton Beach Brands
HBB
$489M
| $11.8K | ﹤0.01% |
700
-700
| -50% | -$16.2K |
2024 Q1
3 quarters
|
|
13493
CALL
Cue Biopharma
CUE
$177M
| $11.8K | ﹤0.01% |
360
-120
| -25% | -$4.51K |
2020 Q3
17 quarters
|
|
|
RSVR
13494
CALL
Reservoir Media
RSVR
$630M
| $11.8K | ﹤0.01% |
1,300
| – | – |
2023 Q2
6 quarters
|
|
|
FURY
13495
Fury Gold Mines
FURY
$96.8M
| $11.8K | ﹤0.01% |
31,771
-66,924
| -68% | -$28.4K |
2024 Q3
1 quarter
|
|
13496
Nexa Resources
NEXA
$1.65B
| $11.7K | ﹤0.01% |
1,333
-17,103
| -93% | -$134K |
2020 Q4
16 quarters
|
|
13497
CALL
Standard BioTools
LAB
$300M
| $11.7K | ﹤0.01% |
6,700
-20,500
| -75% | -$38.2K |
2020 Q2
18 quarters
|
|
|
EHAB
13498
CALL
DELISTED
Enhabit
EHAB
| $11.7K | ﹤0.01% |
1,500
-7,000
| -82% | -$53.2K |
2024 Q1
3 quarters
|
|
13499
CALL
Genasys
GNSS
$65.1M
| $11.7K | ﹤0.01% |
4,500
+3,300
| +275% | +$11.6K |
2024 Q3
1 quarter
|
|
13500
CALL
Ranpak Holdings
PACK
$340M
| $11.7K | ﹤0.01% |
1,700
-42,400
| -96% | -$290K |
2022 Q4
8 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.